Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor

Y. Tsukada, H. Nagayama, Takehiko Mori, Takayuki Shimizu, N. Sato, N. Takayama, A. Ishida, M. Handa, Y. Ikeda, Shinichiro Okamoto

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Bacterial meningoencephalitis occurring in the pre-engraftment period after bone marrow transplantation (BMT) is a rare complication, and the feasibility of granulocyte transfusion (GTX) in such cases remains to be elucidated. A 37-year-old man developed enterococcal meningoencephalitis during a severely granulocytopenic pre-engraftment period after BMT. Despite therapy with appropriate antibiotics, cultures of blood and cerebrospinal fluid (CSF) continued to grow Enterococcus faecalis, and he developed rapid mental deterioration and seizure. Granulocytes were collected from his HLA-mismatched, ABO-matched sibling with subcutaneous injection of granulocyte colony-stimulating factor (G-CSF) and oral dexamethazone. Transfusion of 4.4 × 1010 granulocytes resulted in a 12-h post-transfusion granulocyte increment of 2.0 × 109/1, and maintained peripheral blood granulocyte counts above 0.5 × 109/l for 3 days. A rapid increase of granulocytes in CSF was also observed, and cultures of blood and CSF became negative after GTX. A transient worsening of seizure was observed as a potential side effect of GTX. The patient subsequently developed septic shock because of Pseudomonas aeruginosa and died. Further studies are warranted to evaluate the clinical efficacy of GTX for the treatment of uncontrolled infections in granulocytopenic stem cell transplant recipients.

Original languageEnglish
Pages (from-to)69-72
Number of pages4
JournalBone Marrow Transplantation
Volume31
Issue number1
DOIs
Publication statusPublished - 2003 Jan

Fingerprint

Unrelated Donors
Meningoencephalitis
Homologous Transplantation
Bone Marrow Transplantation
Granulocytes
Cerebrospinal Fluid
Seizures
Therapeutics
Enterococcus faecalis
Granulocyte Colony-Stimulating Factor
Subcutaneous Injections
Septic Shock
Pseudomonas aeruginosa
Siblings
Stem Cells
Anti-Bacterial Agents
Transplants
Infection

Keywords

  • Bone marrow transplantation
  • Enterococcus
  • G-CSF
  • Granulocyte transfusion
  • Meningoencephalitis

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor. / Tsukada, Y.; Nagayama, H.; Mori, Takehiko; Shimizu, Takayuki; Sato, N.; Takayama, N.; Ishida, A.; Handa, M.; Ikeda, Y.; Okamoto, Shinichiro.

In: Bone Marrow Transplantation, Vol. 31, No. 1, 01.2003, p. 69-72.

Research output: Contribution to journalArticle

@article{f3395badf0f6452f80efabd924dd90ae,
title = "Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor",
abstract = "Bacterial meningoencephalitis occurring in the pre-engraftment period after bone marrow transplantation (BMT) is a rare complication, and the feasibility of granulocyte transfusion (GTX) in such cases remains to be elucidated. A 37-year-old man developed enterococcal meningoencephalitis during a severely granulocytopenic pre-engraftment period after BMT. Despite therapy with appropriate antibiotics, cultures of blood and cerebrospinal fluid (CSF) continued to grow Enterococcus faecalis, and he developed rapid mental deterioration and seizure. Granulocytes were collected from his HLA-mismatched, ABO-matched sibling with subcutaneous injection of granulocyte colony-stimulating factor (G-CSF) and oral dexamethazone. Transfusion of 4.4 × 1010 granulocytes resulted in a 12-h post-transfusion granulocyte increment of 2.0 × 109/1, and maintained peripheral blood granulocyte counts above 0.5 × 109/l for 3 days. A rapid increase of granulocytes in CSF was also observed, and cultures of blood and CSF became negative after GTX. A transient worsening of seizure was observed as a potential side effect of GTX. The patient subsequently developed septic shock because of Pseudomonas aeruginosa and died. Further studies are warranted to evaluate the clinical efficacy of GTX for the treatment of uncontrolled infections in granulocytopenic stem cell transplant recipients.",
keywords = "Bone marrow transplantation, Enterococcus, G-CSF, Granulocyte transfusion, Meningoencephalitis",
author = "Y. Tsukada and H. Nagayama and Takehiko Mori and Takayuki Shimizu and N. Sato and N. Takayama and A. Ishida and M. Handa and Y. Ikeda and Shinichiro Okamoto",
year = "2003",
month = "1",
doi = "10.1038/sj.bmt.1703780",
language = "English",
volume = "31",
pages = "69--72",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor

AU - Tsukada, Y.

AU - Nagayama, H.

AU - Mori, Takehiko

AU - Shimizu, Takayuki

AU - Sato, N.

AU - Takayama, N.

AU - Ishida, A.

AU - Handa, M.

AU - Ikeda, Y.

AU - Okamoto, Shinichiro

PY - 2003/1

Y1 - 2003/1

N2 - Bacterial meningoencephalitis occurring in the pre-engraftment period after bone marrow transplantation (BMT) is a rare complication, and the feasibility of granulocyte transfusion (GTX) in such cases remains to be elucidated. A 37-year-old man developed enterococcal meningoencephalitis during a severely granulocytopenic pre-engraftment period after BMT. Despite therapy with appropriate antibiotics, cultures of blood and cerebrospinal fluid (CSF) continued to grow Enterococcus faecalis, and he developed rapid mental deterioration and seizure. Granulocytes were collected from his HLA-mismatched, ABO-matched sibling with subcutaneous injection of granulocyte colony-stimulating factor (G-CSF) and oral dexamethazone. Transfusion of 4.4 × 1010 granulocytes resulted in a 12-h post-transfusion granulocyte increment of 2.0 × 109/1, and maintained peripheral blood granulocyte counts above 0.5 × 109/l for 3 days. A rapid increase of granulocytes in CSF was also observed, and cultures of blood and CSF became negative after GTX. A transient worsening of seizure was observed as a potential side effect of GTX. The patient subsequently developed septic shock because of Pseudomonas aeruginosa and died. Further studies are warranted to evaluate the clinical efficacy of GTX for the treatment of uncontrolled infections in granulocytopenic stem cell transplant recipients.

AB - Bacterial meningoencephalitis occurring in the pre-engraftment period after bone marrow transplantation (BMT) is a rare complication, and the feasibility of granulocyte transfusion (GTX) in such cases remains to be elucidated. A 37-year-old man developed enterococcal meningoencephalitis during a severely granulocytopenic pre-engraftment period after BMT. Despite therapy with appropriate antibiotics, cultures of blood and cerebrospinal fluid (CSF) continued to grow Enterococcus faecalis, and he developed rapid mental deterioration and seizure. Granulocytes were collected from his HLA-mismatched, ABO-matched sibling with subcutaneous injection of granulocyte colony-stimulating factor (G-CSF) and oral dexamethazone. Transfusion of 4.4 × 1010 granulocytes resulted in a 12-h post-transfusion granulocyte increment of 2.0 × 109/1, and maintained peripheral blood granulocyte counts above 0.5 × 109/l for 3 days. A rapid increase of granulocytes in CSF was also observed, and cultures of blood and CSF became negative after GTX. A transient worsening of seizure was observed as a potential side effect of GTX. The patient subsequently developed septic shock because of Pseudomonas aeruginosa and died. Further studies are warranted to evaluate the clinical efficacy of GTX for the treatment of uncontrolled infections in granulocytopenic stem cell transplant recipients.

KW - Bone marrow transplantation

KW - Enterococcus

KW - G-CSF

KW - Granulocyte transfusion

KW - Meningoencephalitis

UR - http://www.scopus.com/inward/record.url?scp=0037261449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037261449&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1703780

DO - 10.1038/sj.bmt.1703780

M3 - Article

C2 - 12621511

AN - SCOPUS:0037261449

VL - 31

SP - 69

EP - 72

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 1

ER -